Logo

Editor's Pick

Universal DX Eyeing Approval for Colorectal Cancer Early Detection Test After Positive Data
Premium

The firm plans to present data from a large validation study of the Signal-C early detection test later this year as it contemplates approval.

Ampel BioSolutions, Duke Researchers Establish Fibromyalgia Gene Signature
Premium

Ampel will use the signature to develop FibroGene, a fibromyalgia blood test that the company expects to launch next year.

New Study Results Boost Evidence for Natera's MRD Assays to Guide Adjuvant Therapy Decisions
Premium

The data, from a large prospective cohort, support the value of chemotherapy for ctDNA-positive patients, regardless of clinical stage.

Colorectal Cancer Detection Data from CellMax Life Bodes Well for Planned FDA Bid
Premium

The company believes the new results, from an initial prospective multisite trial, reflect what it can achieve in the larger cohort that it is now planning to recruit.

Rebranded GeneDx Bets Future on Whole-Exome, Whole-Genome Sequencing in Pediatric Rare Disease
Premium

After dropping underdeveloped Sema4 business lines but emphasizing the Centrellis informatics platform, the new GeneDx expects to reach profitability by 2025.

Jan 4, 2023

Absent Resolution on FDA's LDT Oversight in 2022, Some Payors Began Advancing Their Own Requirements
Premium

Dec 8, 2022

Analysis of CMS Data Raises Alarm on Potential Genetic Testing Fraud
Premium

Nov 28, 2022

Juno Diagnostics Lowers Barriers to Noninvasive Prenatal Testing With At-Home Sample Collection
Premium

Nov 22, 2022

Foundation Medicine Probing Tumor Fraction Influence on Negative Liquid Biopsies
Premium

Nov 22, 2022

As Alzheimer's Dx Comparison Study Wraps Up, Researchers Plan to Add Genomic, Proteomic Profiling
Premium

Nov 18, 2022

UCLA Team Uses Magnets, Microfluidics to Create Handheld Molecular Dx System
Premium

Nov 17, 2022

Haystack Oncology to Debut Hypersensitive Residual Cancer Test Based on Hopkins Tech
Premium

Nov 3, 2022

UK Startup LEX Diagnostics Developing Ultra-Fast Low-Cost PCR for Infectious Disease Dx
Premium

Nov 1, 2022

Myriad Genetics to Submit Hereditary Cancer Risk Variants to ClinVar in 2023
Premium

Oct 31, 2022

Angle Finalizes Plans for First Clinical CTC Test in Ovarian Cancer
Premium

Oct 20, 2022

Meet Ravgen, the Little-Known Company Rattling NIPTs Biggest Players in Court
Premium

Oct 18, 2022

Real-Time Surveillance Sequencing Shows Promise for Hospital Outbreak Detection, Prevention
Premium

Oct 10, 2022

Genomic Newborn Screening Studies Around the World Begin to Take Baby Steps
Premium

Oct 4, 2022

Nonprofit's Efforts With Payors to Assess NGS Labs' Variant Interpretations Spark Debate
Premium

Oct 3, 2022

Highmark Asks Labs for Additional Validation Data on Cancer NGS Tests; Will Other Insurers Follow?
Premium

Sep 29, 2022

MasSpec Pen Developers Looking to Move Into Microbial Identification
Premium

Sep 13, 2022

Pediatric Patients Face Barriers Receiving Exome Sequencing From Insurance, Scheduling Delays
Premium

Sep 7, 2022

Larger Liquid Biopsy Panels Loom, But Patient Benefit Still Uncertain
Premium

Aug 30, 2022

UK's NICE to Assess Use of CYP2C19 Tests for Guiding Therapy Selection in Stroke Patients
Premium

Aug 25, 2022

Senate Bill Proposes Bringing Back Patents on Genes
Premium